Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption
Nina Deka, Senior Research Analyst at ROBO Global, points out some huge problems in the healthcare industry that are ripe for innovative solutions. After looking at some of five major themes, Nina revisits some stocks from her last appearance like 1Life Healthcare (ONEM) and Teladoc (TDOC) as well as the stories behind Tabula Rasa (TRHC) Akoya BioSciences (AKYA), Catalent (CTLT), Dexcom (DXCM) and Fate Therapeutics (FATE). For the video version, show notes and charts, visit investors.com/podcast.